nemtabrutinib
Showing 1 - 7 of 7
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Nemtabrutinib
- +2 more
- (no location specified)
Nov 22, 2023
Mature B-cell Tumors Trial (Nemtabrutinib)
Not yet recruiting
- Mature B-cell Neoplasms
- Nemtabrutinib
- (no location specified)
Jan 13, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,
Not yet recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +5 more
- Nemtabrutinib
- +2 more
- (no location specified)
Jul 21, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Leukemia
- Nemtabrutinib
- +7 more
- (no location specified)
Nov 30, 2022
Hematological Malignancies Trial in Guangzhou, Tianjin (Nemtabrutinib)
Recruiting
- Hematological Malignancies
- Nemtabrutinib
-
Guangzhou, Guangdong, China
- +2 more
Aug 10, 2022
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in Spokane, Salamanca (Zilovertamab vedotin,
Recruiting
- Chronic Lymphocytic Leukemia
- +3 more
- Zilovertamab vedotin
- Nemtabrutinib
-
Spokane, Washington
- +1 more
Aug 12, 2022
Hematologic Malignancies Trial in Worldwide (Nemtabrutinib)
Recruiting
- Hematologic Malignancies
- Nemtabrutinib
-
Torrance, California
- +51 more
Jan 12, 2023